Modelling fluorescence in clinical photodynamic therapy

Ronan M. Valentine, Sally H. Ibbotson, Kenny Wood, C. Tom A. Brown, Harry Moseley

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Abstract

    Understanding the interactions of non-ionizing radiation with living organisms has been the focus of much research over recent decades. The complex nature of these interactions warrants development of theoretical and experimental studies to gain an insight into predicting and monitoring the success of photodynamic therapy (PDT) protocols. There is a major impetus towards evidence-based recommendations for patient diagnosis, treatment and management. Knowledge of the biophysical aspects of PDT is important for improving dosimetry protocols. Fluorescence in clinical PDT may be used to detect and diagnose pre-malignant and malignant conditions, while photobleaching can monitor changes in fluorescence during treatment. Combining empirical fluorescence photobleaching clinical data with computational modelling enables clinical PDT dosimetry protocols to be investigated with a view to optimising treatment regimes. We will discuss how Monte Carlo radiation transfer (MCRT) modelling has been intercalated in the field of fluorescence detection and PDT. In this paper we highlight important aspects of basic research in PDT by reporting on the current utilisation of fluorescence in clinical PDT from both a clinical and theoretical perspective. Understanding and knowledge of light propagation in biological tissue from these perspectives should have a positive impact on treatment planning.
    Original languageEnglish
    Pages (from-to)203-213
    Number of pages11
    JournalPhotochemical & Photobiological Sciences
    Volume12
    Issue number1
    DOIs
    Publication statusPublished - Jan 2013

    Fingerprint

    Photodynamic therapy
    therapy
    Fluorescence
    fluorescence
    Photobleaching
    Dosimetry
    dosimeters
    Light propagation
    radiation
    organisms
    recommendations
    planning
    interactions
    Tissue
    Radiation
    Planning
    propagation
    Monitoring

    Keywords

    • Photosensitizing Agents
    • Spectrometry, Fluorescence
    • Skin Diseases
    • Radiometry
    • Photobleaching
    • Humans
    • Photochemotherapy
    • Skin Neoplasms
    • Protoporphyrins
    • Monte Carlo Method
    • Models, Theoretical
    • Aminolevulinic Acid

    Cite this

    Valentine, Ronan M. ; Ibbotson, Sally H. ; Wood, Kenny ; Brown, C. Tom A. ; Moseley, Harry. / Modelling fluorescence in clinical photodynamic therapy. In: Photochemical & Photobiological Sciences. 2013 ; Vol. 12, No. 1. pp. 203-213.
    @article{d4c4e7b09b8a4f82ac7faba99c7e6701,
    title = "Modelling fluorescence in clinical photodynamic therapy",
    abstract = "Understanding the interactions of non-ionizing radiation with living organisms has been the focus of much research over recent decades. The complex nature of these interactions warrants development of theoretical and experimental studies to gain an insight into predicting and monitoring the success of photodynamic therapy (PDT) protocols. There is a major impetus towards evidence-based recommendations for patient diagnosis, treatment and management. Knowledge of the biophysical aspects of PDT is important for improving dosimetry protocols. Fluorescence in clinical PDT may be used to detect and diagnose pre-malignant and malignant conditions, while photobleaching can monitor changes in fluorescence during treatment. Combining empirical fluorescence photobleaching clinical data with computational modelling enables clinical PDT dosimetry protocols to be investigated with a view to optimising treatment regimes. We will discuss how Monte Carlo radiation transfer (MCRT) modelling has been intercalated in the field of fluorescence detection and PDT. In this paper we highlight important aspects of basic research in PDT by reporting on the current utilisation of fluorescence in clinical PDT from both a clinical and theoretical perspective. Understanding and knowledge of light propagation in biological tissue from these perspectives should have a positive impact on treatment planning.",
    keywords = "Photosensitizing Agents, Spectrometry, Fluorescence, Skin Diseases, Radiometry, Photobleaching, Humans, Photochemotherapy, Skin Neoplasms, Protoporphyrins, Monte Carlo Method, Models, Theoretical, Aminolevulinic Acid",
    author = "Valentine, {Ronan M.} and Ibbotson, {Sally H.} and Kenny Wood and Brown, {C. Tom A.} and Harry Moseley",
    year = "2013",
    month = "1",
    doi = "10.1039/c2pp25271f",
    language = "English",
    volume = "12",
    pages = "203--213",
    journal = "Photochemical & Photobiological Sciences",
    issn = "1474-905X",
    publisher = "Royal Society of Chemistry",
    number = "1",

    }

    Modelling fluorescence in clinical photodynamic therapy. / Valentine, Ronan M.; Ibbotson, Sally H.; Wood, Kenny; Brown, C. Tom A.; Moseley, Harry.

    In: Photochemical & Photobiological Sciences, Vol. 12, No. 1, 01.2013, p. 203-213.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Modelling fluorescence in clinical photodynamic therapy

    AU - Valentine, Ronan M.

    AU - Ibbotson, Sally H.

    AU - Wood, Kenny

    AU - Brown, C. Tom A.

    AU - Moseley, Harry

    PY - 2013/1

    Y1 - 2013/1

    N2 - Understanding the interactions of non-ionizing radiation with living organisms has been the focus of much research over recent decades. The complex nature of these interactions warrants development of theoretical and experimental studies to gain an insight into predicting and monitoring the success of photodynamic therapy (PDT) protocols. There is a major impetus towards evidence-based recommendations for patient diagnosis, treatment and management. Knowledge of the biophysical aspects of PDT is important for improving dosimetry protocols. Fluorescence in clinical PDT may be used to detect and diagnose pre-malignant and malignant conditions, while photobleaching can monitor changes in fluorescence during treatment. Combining empirical fluorescence photobleaching clinical data with computational modelling enables clinical PDT dosimetry protocols to be investigated with a view to optimising treatment regimes. We will discuss how Monte Carlo radiation transfer (MCRT) modelling has been intercalated in the field of fluorescence detection and PDT. In this paper we highlight important aspects of basic research in PDT by reporting on the current utilisation of fluorescence in clinical PDT from both a clinical and theoretical perspective. Understanding and knowledge of light propagation in biological tissue from these perspectives should have a positive impact on treatment planning.

    AB - Understanding the interactions of non-ionizing radiation with living organisms has been the focus of much research over recent decades. The complex nature of these interactions warrants development of theoretical and experimental studies to gain an insight into predicting and monitoring the success of photodynamic therapy (PDT) protocols. There is a major impetus towards evidence-based recommendations for patient diagnosis, treatment and management. Knowledge of the biophysical aspects of PDT is important for improving dosimetry protocols. Fluorescence in clinical PDT may be used to detect and diagnose pre-malignant and malignant conditions, while photobleaching can monitor changes in fluorescence during treatment. Combining empirical fluorescence photobleaching clinical data with computational modelling enables clinical PDT dosimetry protocols to be investigated with a view to optimising treatment regimes. We will discuss how Monte Carlo radiation transfer (MCRT) modelling has been intercalated in the field of fluorescence detection and PDT. In this paper we highlight important aspects of basic research in PDT by reporting on the current utilisation of fluorescence in clinical PDT from both a clinical and theoretical perspective. Understanding and knowledge of light propagation in biological tissue from these perspectives should have a positive impact on treatment planning.

    KW - Photosensitizing Agents

    KW - Spectrometry, Fluorescence

    KW - Skin Diseases

    KW - Radiometry

    KW - Photobleaching

    KW - Humans

    KW - Photochemotherapy

    KW - Skin Neoplasms

    KW - Protoporphyrins

    KW - Monte Carlo Method

    KW - Models, Theoretical

    KW - Aminolevulinic Acid

    U2 - 10.1039/c2pp25271f

    DO - 10.1039/c2pp25271f

    M3 - Article

    VL - 12

    SP - 203

    EP - 213

    JO - Photochemical & Photobiological Sciences

    JF - Photochemical & Photobiological Sciences

    SN - 1474-905X

    IS - 1

    ER -